GlycoSolutions

GlycoSolutions is a specialized contract research organization (CRO) providing comprehensive glycan analysis and characterization services for the biopharmaceutical industry. The company focuses on the detailed structural analysis of glycoproteins, including monoclonal antibodies, fusion proteins, and other recombinant biologics. Their expertise includes N-linked and O-linked glycan profiling, monosaccharide analysis, and sialic acid quantification to support drug development and quality control. By utilizing advanced mass spectrometry and liquid chromatography techniques, GlycoSolutions helps clients ensure the consistency and efficacy of their therapeutic candidates. The firm provides critical data required for CMC sections of regulatory filings for both novel biologics and biosimilars. Based in Massachusetts, the company serves a global client base ranging from small biotech startups to large pharmaceutical corporations.